- Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs CNBC
- Hims shares shoot up after weight-loss drug deal with Novo Nordisk Financial Times
- Hims & Hers Announces Strategic Shift for US Weight Loss Business HIMS Investor Relations
- Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers WSJ
- Hims & Hers stock surges as Novo Nordisk says it will distribute weight-loss drugs on platform Yahoo Finance
- Hims & Hers Stock Soars. Its Weight-Loss Drug Battle With Novo Nordisk Takes a Surprising Twist. Barron’s
- Hims & Hers: Repartnering With Novo Removes Legal Overhang and Reshapes Weight Loss Segment Morningstar
- Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration PBS
- Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform MarketWatch
Brought to you by Google News. Read the rest of the article here